Cholinergic modulation of dopamine release in corpus striatum and substantia nigra of the rat. 1992

M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
Istituto di Farmacologia e Farmacognosia, Università degli Studi di Genova, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D009411 Nerve Endings Branch-like terminations of NERVE FIBERS, sensory or motor NEURONS. Endings of sensory neurons are the beginnings of afferent pathway to the CENTRAL NERVOUS SYSTEM. Endings of motor neurons are the terminals of axons at the muscle cells. Nerve endings which release neurotransmitters are called PRESYNAPTIC TERMINALS. Ending, Nerve,Endings, Nerve,Nerve Ending
D010095 Oxotremorine A non-hydrolyzed muscarinic agonist used as a research tool. Oxytremorine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D003712 Dendrites Extensions of the nerve cell body. They are short and branched and receive stimuli from other NEURONS. Dendrite
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
September 1991, Naunyn-Schmiedeberg's archives of pharmacology,
M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
April 1978, European journal of pharmacology,
M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
July 1993, British journal of pharmacology,
M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
October 1976, Life sciences,
M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
April 1999, Synapse (New York, N.Y.),
M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
March 1969, Experimental neurology,
M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
November 1976, European journal of pharmacology,
M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
March 1976, Nature,
M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
March 1976, Nature,
M Marchi, and G Volpe, and A Augliera, and A Codignola, and G Lunardi, and M Raiteri
February 1977, Life sciences,
Copied contents to your clipboard!